Biotech · Private company · San Diego, CA, US
Vala Sciences, Inc.
Track this companyFree. Adds Vala Sciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- An assay suite featuring hiPSC-derived neurons and support cells, to test toxicants and industrial chemicals for developmental neurotoxic effectsFiscal year 2025 · $755.7KNIH RePORTER 5R44ES036385-02 · fetched Nov 12, 2026
- Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs)Fiscal year 2025 · $1.1MNIH RePORTER 5R44MH135526-03 · fetched Nov 12, 2026
- An assay suite featuring hiPSC-derived neurons and support cells, to test toxicants and industrial chemicals for developmental neurotoxic effectsFiscal year 2024 · $1.2MNIH RePORTER 1R44ES036385-01 · fetched Nov 12, 2026
- Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived CardiomyocytesFiscal year 2024 · $120.5KNIH RePORTER 3R42HL158510-02S1 · fetched Nov 12, 2026
- Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived CardiomyocytesFiscal year 2024 · $16.9KNIH RePORTER 3R42HL158510-02S2 · fetched Nov 12, 2026
- Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived CardiomyocytesFiscal year 2024 · $9.5KNIH RePORTER 3R42HL158510-02S3 · fetched Nov 12, 2026
- Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived CardiomyocytesFiscal year 2024 · $174KNIH RePORTER 3R42HL158510-03S1 · fetched Nov 12, 2026
- Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived CardiomyocytesFiscal year 2024 · $13.6KNIH RePORTER 3R42HL158510-03S2 · fetched Nov 12, 2026
- Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived CardiomyocytesFiscal year 2024 · $152.8KNIH RePORTER 3R42HL158510-03S3 · fetched Nov 12, 2026
- Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs)Fiscal year 2024 · $1.1MNIH RePORTER 4R44MH135526-02 · fetched Nov 12, 2026